JORDONA NDON: Open Payments
NPI 1336530146 · STAFFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 31 payments from 11 companies in 2025. Trend: 2023 $421 · 2024 $1,716 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $370 |
| Amgen Inc. | 4 | $96 |
| Incyte Corporation | 4 | $86 |
| ABBVIE INC. | 3 | $63 |
| Organon LLC | 2 | $47 |
| Galderma Laboratories, L.P. | 2 | $42 |
| PFIZER INC. | 2 | $42 |
| Lilly USA, LLC | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $27 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
Products named: DUPIXENT, OTEZLA, Opzelura, NEMLUVIO, CIBINQO, SKYRIZI, TALTZ, TREMFYA.
Industry payments across VA — which companies pay providers there.
